In 2025, U.S. healthcare policy reached a clear inflection point. After decades of federal and state policy serving primarily as a mechanism for coverage expansion, policymakers turned to cost containment, efficiency, and operational discipline as central objectives. Across Medicare, Medicaid, and the commercial market, policy levers were deployed more aggressively to slow national healthcare spending growth, reshape incentives, and push the system toward technology-enabled, outcomes-oriented care.
A defining feature of the year was the explicit expectation that stakeholders do more with less. Federal agencies emphasized efficiency, prevention, and automation, accelerating interest in AI, digital health tools, and data-driven care management. At the same time, providers and payers faced sustained margin pressure driven by high utilization, medical cost trends, and reimbursement that often failed to keep pace with inflation. These forces combined to shift organizational focus away from experimentation and toward operational execution.
State Policy: Implementation Over Innovation
For states, 2025 was largely about compliance and execution. Major federal legislative and regulatory changes required states to devote significant capacity to budgeting, eligibility processes, benefit design, systems modernization, and rural health planning. Coverage churn was a second-order driver of state and provider strain. As a result, implementation displaced experimentation. Many states deferred new pilots or delivery system reforms in favor of meeting near-term operational requirements.
Fiscal tradeoffs reinforced this dynamic. Constrained budgets forced states to prioritize core program sustainability, often pushing secondary initiatives into later years. These pressures influenced decisions around rate setting, managed care contracting, and long-term services and supports (LTSS), reframing how and when states were willing to test innovation or expand value-based approaches.
Managed Care Under Pressure
In Medicaid managed care, the emphasis similarly shifted toward “must-do” activities: eligibility changes, program integrity, complex care management, and readiness for new federal requirements. Broader benefit expansions and ambitious integration efforts, including Medicare–Medicaid alignment, generally took a back seat.
Medicare Advantage (MA) experienced another year of margin compression, which materially shaped plan behavior. Plans tightened benefit designs, scrutinized administrative spending, and focused capital on markets and products with clearer paths to sustainability. The continued pullback from some non–special needs plans contrasted with steady growth in dual eligible and chronic condition special needs plans (D-SNPs and C-SNPs, respectively), alongside deeper plan–provider partnerships designed to protect margins.
While near-term MA policy appeared relatively stable, regulatory signals pointed toward future reform. Requests for information and policy discussions around risk adjustment, quality programs, and coding suggested that plans must continue to manage medium- and long-term regulatory uncertainty, even during periods of short-term steadiness.
CMS Innovation Center Activity and Value-Based Care Evolution
The CMS Innovation Center played an outsized role in shaping market expectations in 2025. The launch of longer-horizon models including ACCESS signaled a sustained federal commitment to testing new payment and delivery approaches, particularly those enabled by technology. These models increasingly emphasized measurable outcomes, consumer-facing tools, and clear pathways for commercialization.
The accountable care organization (ACO) landscape also shifted. Traditional shared-savings models remained foundational, while more advanced tracks demanded greater sophistication in complex care management, downside risk, and integration with post-acute and community-based services. Specialty care episodes, bundled payments, and emerging models further complicated the landscape, reinforcing the need for strong analytics and operational readiness.
Persistent Stress Points: Hospitals, Pharmacy, and Long-Term Care
Financial pressure remained acute for hospitals and health systems. Even as some labor cost growth moderated, reimbursement challenges and coverage churn increased uncompensated care risk and debt exposure, weighing heavily on balance sheets. In many markets, the operational burden of eligibility transfers translated directly into financial stress for hospitals and safety-net providers, especially where Medicaid volumes are high and commercial offsets are limited. Post-acute providers experienced mixed signals, with some regulatory relief for skilled nursing facilities alongside continued payment pressure for home health agencies.
Policy momentum around site neutrality and continued site-of-care shifts amplified pressure, as volume migrates away from hospital-based care. At the same time, risk exposure to uncompensated care increased with new statutory requirements tied to Medicaid eligibility.
The pharmacy ecosystem emerged as a cross-cutting stress point. Drug pricing reforms, reimbursement dynamics, and scrutiny of pharmacy benefit managers exposed structural vulnerabilities that affected plans, providers, and beneficiaries alike. Alongside this, rapid growth in GLP-1 utilization and specialty drug spend pushed to the forefront of cost management, reshaping utilization management, benefit design, and contracting strategies. Market exits and consolidation underscored the scale of disruption underway. Stakeholders continued to test new pharmacy pricing and distribution approaches –including direct to consumer channels, adding competitive pressure to traditional dispensing models and economics.
Meanwhile, demographic trends kept dementia care, caregiving, and LTSS firmly on the policy agenda. Although these issues moved closer to the mainstream in 2025, concrete action lagged stated urgency.
What to Watch in 2026
Looking ahead, several themes are likely to shape the healthcare landscape in 2026.
- State signals and funding priorities. Early allocation decisions tied to new federal funding streams and emerging regulations will offer insight into state priorities, preferred delivery models, and the partners positioned to scale.
- Operational strain in Medicaid. States will continue to juggle complex eligibility changes, systems updates, and forthcoming managed care and access requirements, limiting bandwidth for discretionary initiatives.
- Medicare Advantage recalibration. Final rules, demonstration announcements, and plan responses will influence coding practices, value-based contracting, and market participation, particularly in counties experiencing recent plan exits.
- A potential thaw in value-based care. Longer demonstration timelines and clearer payment pathways may encourage providers to re-engage with risk-based models, provided they can validate outcomes and manage financial exposure.
- Technology selection and scaling. After a year of capability building, organizations are expected to narrow their focus to AI and digital tools that are auditable, compliant, and clearly tied to cost reduction or outcome improvement.
- Sustained pharmacy and drug pricing pressure. Ongoing federal demonstrations and policy follow-through will continue to reshape contracting, utilization management, dispensing economics, and the role of pharmacies over multiple years.
Healthcare’s next phase will likely be defined less by rapid expansion and more by disciplined execution. In 2026, the organizations best positioned to navigate this environment will be those that align operational readiness, financial sustainability, and evidence-based innovation within an increasingly cost-conscious policy framework.